GENE EXPRESSION AND KETAMINE RESPONSE IN SUBJECTS WITH TREATMENT RESISTANT DEPRESSION

被引:0
|
作者
Sahra, Mohazzab-Hosseinian [1 ]
Pirooznia, Mehdi [2 ]
Zandi, Peter [3 ]
Goes, Fernando [3 ]
机构
[1] Johns Hopkins Sch Publ Hlth, Baltimore, MD USA
[2] Johns Hopkins Sch Med, Baltimore, MD USA
[3] Johns Hopkins Univ, Baltimore, MD 21218 USA
关键词
D O I
10.1016/j.euroneuro.2019.07.201
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
60
引用
收藏
页码:S93 / S93
页数:1
相关论文
共 50 条
  • [41] Search for biomarkers for ketamine response from changes of cytokines in the patients with treatment resistant depression
    Su, Tung-Ping
    Chen, Mu-Hong
    Li, Cheng-Da
    Bai, Ya-Mei
    Chang, Annie
    Wu, Hui-Ju
    Lin, Wei-Chen
    Tu, Pei-Chi
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 82 - 83
  • [42] Features of dissociation differentially predict antidepressant response to ketamine in treatment-resistant depression
    Niciu, Mark J.
    Shovestul, Bridget J.
    Jaso, Brittany A.
    Farmer, Cristan
    Luckenbaugh, David A.
    Brutsche, Nancy E.
    Park, Lawrence T.
    Ballard, Elizabeth D.
    Zarat, Carlos A., Jr.
    JOURNAL OF AFFECTIVE DISORDERS, 2018, 232 : 310 - 315
  • [43] D-serine plasma concentration is a potential biomarker of (R,S)-ketamine antidepressant response in subjects with treatment-resistant depression
    Moaddel, Ruin
    Luckenbaugh, David A.
    Xie, Ying
    Villasenor, Alma
    Brutsche, Nancy E.
    Machado-Vieira, Rodrigo
    Ramamoorthy, Anuradha
    Paz Lorenzo, Maria
    Garcia, Antonia
    Bernier, Michel
    Torjman, Marc C.
    Barbas, Coral
    Zarate, Carlos A., Jr.
    Wainer, Irving W.
    PSYCHOPHARMACOLOGY, 2015, 232 (02) : 399 - 409
  • [44] KETAMINE FOR TREATMENT-RESISTANT DEPRESSION: A NEW ADVOCATE
    Perez-Esparza, Rodrigo
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2018, 70 (02): : 65 - 67
  • [45] Following Ketamine Infusion in Individuals With Treatment Resistant Depression
    Deckersbach, Thilo
    Testo, Abigail
    Ionescu, Dawn
    Felicione, Julia
    Akeju-Johnson, Oluwaseun
    Cheung, Joey
    Kubicki, Marek
    Cusin, Christina
    Dougherty, Darin
    NEUROPSYCHOPHARMACOLOGY, 2018, 43 : S308 - S309
  • [46] INTRAVENOUS KETAMINE FOR TREATMENT-RESISTANT DEPRESSION IN ADOLESCENTS?
    Cullen, Kathryn R.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2016, 55 (10): : S284 - S284
  • [47] The role of intranasal ketamine in treatment-resistant depression
    Costa, M.
    Fraga, M.
    Moutinho, A.
    Cintra, P.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 53 : S492 - S492
  • [48] SUICIDALITY IN TREATMENT RESISTANT DEPRESSION: PERSPECTIVE FOR KETAMINE USE
    Jakuszkowiak-Wojten, Katarzyna
    Galuszko-Wegielnik, Maria
    Wilkowska, Alina
    Slupski, Jakub
    Wlodarczyk, Adam
    Gorska, Natalia
    Szarmach, Joanna
    Szalach, Lukasz P.
    Wiglusz, Mariusz S.
    Krysta, Krzysztof
    Cubala, Wieslaw Jerzy
    PSYCHIATRIA DANUBINA, 2019, 31 : S258 - S260
  • [49] Maintenance Ketamine Therapy for Treatment-Resistant Depression
    Archer, Shaina
    Chrenek, Carson
    Swainson, Jennifer
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2018, 38 (04) : 380 - 384
  • [50] Magnesium in Ketamine Administration in Treatment-Resistant Depression
    Gorska, Natalia
    Cubala, Wieslaw Jerzy
    Slupski, Jakub
    Wiglusz, Mariusz Stanislaw
    Galuszko-Wegielnik, Maria
    Kawka, Mateusz
    Grzegorzewska, Agata
    PHARMACEUTICALS, 2021, 14 (05)